ERBB2 and breast carcinoma: Interestingly, the strongly positive rate of Tiam1 expression was 47.3 % (53/112) in breast cancers with HER2 negative expression, but only 29.3 % (12/41) in case with HER2 positive expression (P = 0.046) (Fig. 3).